Can a Popular Antidepressant Cause Teenage Suicide? Boston Globe Wed, 6 Aug 2003 For years, drug manufacturers and regulators (in the UK and US) have falsely maintained that antidepressants–such as Paxil (Seroxat), Prozac, and the other SSRIs–reduce the risk of suicide, and, they maintained, the drugs are not addictive. An…
FDA Orders Black Box Warnings on Antidepressants labels and Patient Information Guides to Warn about Suicide risk Fri, 15 Oct 2004 We have won the first battle in a struggle for full disclose of serious adverse drug effects and disclosure of failed clinical trials. Prescribing physicians and the public have…
Prescription for Suicide? TIME MAGAZINE Fri, 6 Feb 2004 TIME magazine asks whether antidepressants are a Prescription for Suicide. Shannon Baker, whose 12 year old daughter, Kara Jaye-Anne Otter, committed suicide when she had been on the antidepressant Paxil for seven months, recalls: “I was told the worst side effects…
ADHD drug – Cylert withdrawn from market due to Liver Toxicity, a Major Risk of Psychotropic Drugs Tue, October 25, 2005 The FDA announced that another drug prescribed for ADHD–Cylert–was removed from the US market for safety reasons. On September 25, 2005, the Associated Press reported: “Eli Lilly said it…
When Doctors Learn, Drug Firms Often Pay th eTab – Philly Inquirer Wed, 8 Jun 2005 The Philadelphia Inquirer reports about the blinders that academic medical institutions and physicians (in this instance psychiatrists) put on pretending not to know that they have surrendered the integrity of medicine and medical education…
Eli Lilly Prozac Documents: What do They Reveal? Thu, 27 Jan 2005 A report in the BMJ (formerly the British Medical Journal) that relied on internal Eli Lilly documents to challenge Lilly’s claims about the safety of Prozac has stirred a prickly hornet’s nest. [1] The documents show, among other…
Federal Study Finds No Benefit of New Antipsychotic Drugs – WashPost/Wall StreetJ/NY Times Tue, 20 Sep 2005 The findings of a $44 million government sponsored study, CATIE, published in The New England Journal of Medicine, comparing an older generic antipsychotic to four new atypical antipsychotics, undercut the legitimacy of psychiatry’s…
A Lobbying Campaign for Screening Children for Mental Problems–a Gimmick Aimed at Increasing PhRMA Profits Wed, 11 May 2005 The big guns of America’s mental health establishment — including the American Psychiatric and Psychological Associations and the National Alliance for the Mentally Ill — are making united front in support…
AHRP Campaign to Protect Children from Harm Oct 15: FDA Orders Black Box Warnings on Antidepressants labels and Patient Information Guides to Warn about Suicide risk Oct 3: BBC PANORAMA TONIGHT – Taken on Trust – 13 years-Medical Deception Sep 30: GSK Sales Reps told NOT to Divulge Paxill Data…
Protecting People with Mental Disabilities and Impairments against Biomedical Research Abuse[*] By John H. Noble, Jr., Ph.D, The Catholic University of America, Washington, DC, USA Vera Hassner Sharav, MLS, Alliance for Human Research Protection, New York, USA People with mental disabilities and impairments historically have been targeted by biomedical researchers…
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav February 19a, 2002 INSANE PSYCHIATRY: AProfession Run Amok FYI Nicholas Regush is an award winning reporter on medicaland scientific issues. For 6 years he was the medical…
FDA reviews depression drugs–Intense or Cautious? WashPost/ NYT/ Herald Wed, 29 Oct 2003 The Washington Post correctly reports: “The association between antidepressants, particularly the selective serotonin reuptake inhibitors (SSRIs), and suicide has been controversial since the first SSRI, Prozac, came on the market in the late 1980s.” But stakeholders in…
